abusesaffiliationarrow-downarrow-leftarrow-rightarrow-upattack-typeburgerchevron-downchevron-leftchevron-rightchevron-upClock iconclosedeletedevelopment-povertydiscriminationdollardownloademailenvironmentexternal-linkfacebookfiltergenderglobegroupshealthC4067174-3DD9-4B9E-AD64-284FDAAE6338@1xinformation-outlineinformationinstagraminvestment-trade-globalisationissueslabourlanguagesShapeCombined Shapeline, chart, up, arrow, graphLinkedInlocationmap-pinminusnewsorganisationotheroverviewpluspreviewArtboard 185profilerefreshIconnewssearchsecurityPathStock downStock steadyStock uptagticktooltiptwitteruniversalityweb
Article

29 Oct 2008

Author:
Soutik Biswas, BBC

Indian drugs boss hails Aids deal

Three years ago, Yusuf K Hamied, head of Indian drugs company Cipla, stunned a European Commission medical meeting in Brussels by offering to sell anti-Aids drugs at a fraction of the going rate...Last week, Dr Hamied won a major victory when former US president Bill Clinton brokered a deal whereby four companies making cheap, generic Aids drugs could begin supplying to millions of people in developing countries...one of them is Cipla, India's third largest drug company.

Timeline